Literature DB >> 13889665

Thioguanine therapy. Systemic lupus erythematosus, atopic dermatitis, and other nonmalignant diseases.

B EISEN, D J DEMIS, W H CROSBY.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC/therapy; DERMATITIS VENENATA/therapy; LUPUS ERYTHEMATOSUS/therapy; MERCAPTOPURINE/related compounds; SCLERODERMA/therapy

Mesh:

Substances:

Year:  1962        PMID: 13889665

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  LUPUS ERYTHEMATOSUS, SYSTEMIC SCLERODERMA AND DERMATOMYOSITIS.

Authors:  C J MCDONALD; R W TURNER
Journal:  J Natl Med Assoc       Date:  1965-01       Impact factor: 1.798

2.  DOSE-RESPONSE RELATIONSHIPS FOR AGENTS INHIBITING THE IMMUNE RESPONSE.

Authors:  M C BERENBAUM; I N BROWN
Journal:  Immunology       Date:  1964-01       Impact factor: 7.397

3.  Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis.

Authors:  M F Kahn; M Bedoiseau; S de Sèze
Journal:  Proc R Soc Med       Date:  1967-02

4.  Peripheral gangrene in infancy and childhood.

Authors:  A Lloyd; M Kemball; G Fraser
Journal:  Br Med J       Date:  1967-02-25

Review 5.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.